The latest price target for Telesis Bio (NASDAQ:TBIO) was reported by Keybanc on August 11, 2023. The analyst firm set a price target for $0.00 expecting TBIO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Telesis Bio (NASDAQ:TBIO) was provided by Keybanc, and Telesis Bio downgraded their sector weight rating.

There is no last upgrade for Telesis Bio

The last downgrade for Telesis Bio Inc happened on August 11, 2023 when Keybanc changed their price target from N/A to N/A for Telesis Bio Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Telesis Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Telesis Bio was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.

While ratings are subjective and will change, the latest Telesis Bio (TBIO) rating was a downgraded with a price target of $0.00 to $0.00. The current price Telesis Bio (TBIO) is trading at is $2.85, which is out of the analyst’s predicted range.